Neutrophil-related immunoinflammatory disturbance in steroid-overdosed ulcerative colitis patients

Journal of Gastroenterology

Volumn 43, Issue 10, 2008, Pages 789-797

  Yoshiyama, Shigeyuki ^a   Miki, Chikao ^a   Okita, Yoshiki ^a   Araki, Toshimitsu ^a   Uchida, Keiichi ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Necrosis; Neutrophil elastase; Neutrophils; Steroid; Ulcerative colitis

Indexed keywords

CD11B ANTIGEN; CD15 ANTIGEN; CD16B ANTIGEN; CYTOKINE; INTERLEUKIN 18; LIPOPOLYSACCHARIDE; LYMPHOCYTE ANTIGEN; MEMBRANE ANTIGEN; PREDNISOLONE; PROTEINASE; STEROID; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIUM CULTURE; BLOOD; CELL DEATH; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG OVERDOSE; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; ILEOANAL ANASTOMOSIS; IMMUNE RESPONSE; INCIDENCE; INFLAMMATION; LEUKAPHERESIS; MALE; MORBIDITY; NEUTROPHIL; OUTCOME ASSESSMENT; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN SECRETION; SURGICAL INFECTION; SURGICAL STRESS; ULCERATIVE COLITIS;

ADULT; APOPTOSIS; COHORT STUDIES; COLITIS, ULCERATIVE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MEMBRANE PROTEINS; NEUTROPHIL ACTIVATION; NEUTROPHILS; PHAGOCYTOSIS; PREDNISOLONE;

EID: 55349114347     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-008-2227-0     Document Type: Article

References (43)

1. MacDermott RP. Alterations of the mucosal immune system in inflammatory bowel disease. J Gastroenterol 1996;31:907-916.
2. Amati L, Caradonna L, Jirillo E, Caccavo D. Immunological disorders in inflammatory bowel disease and immunotherapeutic implications. Ital J Gastroenterol Hepatol 1999;31:313-325.
3. Langhorst J, Elsenbruch S, Mueller T, Rueffer A, Spahn G, Michalsen A, et al. Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis. Inflamm Bowel Dis 2005;11:1085-1091.
4. Kucharzik T, Walsh SV, Chen J, Parkos CA, Nusrat A. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol 2001;159:2001-2009.
5. Israeli E, Grotto I, Gilburd B, Balicer RD, Goldin E, Wiik A, et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005;54:1232-1236.
6. Heuschen UA, Allemeyer EH, Hinz U, Lucas M, Herfarth C, Heuschen G. Outcome after septic complications in J pouch procedures. Br J Surg 2002;89:194-200.
7. Fazio VW, Ziv Y, Church JM, Oakley JR, Lavery IC, Milsom JW, et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 1995;222:120-127.
8. MacRae HM, McLeod RS, Cohen Z, O'Connor BI, Ton EN. Risk factors for pelvic pouch failure. Dis Colon Rectum 1997;40:257-262.
9. Ogunbiyi OA, Korsgen S, Keighley MR. Pouch salvage. Longterm outcome. Dis Colon Rectum 1997;40:548-552.
10. Korsgen S, Nikiteas N, Ogunbiyi OA, Keighley MR. Results from pouch salvage. Br J Surg 1996;83:372-374.
11. Sagar PM, Dozois RR, Wolff BG, Kelly KA. Disconnection, pouch revision and reconnection of the ileal pouch-anal anastomosis. Br J Surg 1996;83:1401-1405.
12. Cohen Z, Smith D, McLeod R. Reconstructive surgery for pelvic pouches. World J Surg 1998;22:342-346.
13. Korsgen S, Keighley MR. Causes of failure and life expectancy of the ileoanal pouch. Int J Colorectal Dis 1997;12:4-8.
14. Seidel SA, Newman M, Sharp KW. Ileoanal pouch versus ileostomy: Is there a difference in quality of life? Am Surg 2000;66:540-546; discussion 546-7.
15. Reissman P, Teoh TA, Weiss EG, Nogueras JJ, Wexner SD. Functional outcome of the double stapled ileoanal reservoir in patients more than 60 years of age. Am Surg 1996;62:178-183.
16. Gemlo BT, Wong WD, Rothenberger DA, Goldberg SM. Ileal pouch-anal anastomosis. Patterns of failure. Arch Surg 1992;127:784-786; discussion 787.
17. Cohen Z, McLeod RS, Stephen W, Stern HS, O'Connor B, Reznick R. Continuing evolution of the pelvic pouch procedure. Ann Surg 1992;216:506-511; discussion 511-2.
18. Ozuner G, Hull T, Lee P, Fazio VW. What happens to a pelvic pouch when a fistula develops? Dis Colon Rectum 1997;40:543-547.
19. Miki C, Ohmori Y, Yoshiyama S, Toiyama Y, Araki T, Uchida K, et al. Factors predicting postoperative infectious complications and early induction of inflammatory mediators in ulcerative colitis patients. World J Surg 2007;31:522-529.
20. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1996;24:380-388.
21. Smith RL, Bohl JK, McElearney ST, Friel CM, Barclay MM, Sawyer RG, et al. Wound infection after elective colorectal resection. Ann Surg 2004;239:599-605; discussion 605-7.
22. Hata K, Watanabe T, Shinozaki M, Nagawa H. Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: Multivariate analysis. Scand J Gastroenterol 2003;38:1055-1058.
23. Hanai H, Takeuchi K, Iida T, Kashiwagi N, Saniabadi AR, Matsushita I. Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis. Dig Dis Sci 2004;49:1438-1443.
24. McCarthy DA, Rampton DS, Liu YC. Peripheral blood neutrophils in inflammatory bowel disease: Morphological evidence of in vivo activation in active disease. Clin Exp Immunol 1991;86:489-493.
25. D'Odorico A, D'Inca R, Mestriner C, Di Leo V, Ferronato A, Sturniolo GC. Influence of disease site and activity on peripheral neutrophil function in inflammatory bowel disease. Dig Dis Sci 2000;45:1594-1600
26. Miki C, Yoshiyama S, Okita Y, Araki T, Uchida K, Yanagi H, et al. Neutrophil priming as a surgery-related risk factor for postoperative infectious complications in patients with ulcerative colitis. Dig Surg 2006;23:179-185.
27. Boyum A. Isolation of leucocytes. Scand J Clin Lab Invest Suppl 1968;97:9-109.
28. Anton PA, Targan SR, Shanahan F. Increased neutrophil receptors for and response to the proinflammatory bacterial peptide formyl-methionyl-leucyl-phenylalanine in Crohn's disease. Gastroenterology 1989;97:20-28.
29. Miki C, Inoue Y, Mohri Y, Kobayashi M, Kusunoki M. Sitespecific patterns of surgical site infections and their early indicators after elective colorectal cancer surgery. Dis Colon Rectum 2006;49:S45-S52.
30. Caradonna L, Amati L, Lella P, Jirillo E, Caccavo D. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease. Am J Gastroenterol 2000;95:1495-1502.
31. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-376.
32. Smith JA. Neutrophils, host defense, and inflammation: A double-edged sword. J Leukoc Biol 1994;56:672-686.
33. Shimizu Y, Miyazaki M, Ito H, Nakagawa K, Ambiru S, Shimizu H. Enhanced polymorphonuclear neutrophil-mediated endothelial cell injury and its relation to high surgical mortality rate in cirrhotic patients. Am J Gastroenterol 1999;94:3297-3303.
34. Young RE, Thompson RD, Larbi KY, La M, Roberts CE, Shapiro SD. Neutrophil elastase (NE)-deficient mice demonstrate a nonredundant role for NE in neutrophil migration, generation of proinflammatory mediators, and phagocytosis in response to zymosan particles in vivo. J Immunol 2004;172:4493-4502.
35. Vandivier RW, Fadok VA, Hoffmann PR, Bratton DL, Penvari C, Brown KK. Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest 2002;109:661-670.
36. Savill J. Apoptosis in resolution of inflammation. J Leukoc Biol 1997;61:375-380.
37. Whyte M, Renshaw S, Lawson R, Bingle C. Apoptosis and the regulation of neutrophil lifespan. Biochem Soc Trans 1999;27:802-807.
38. Dransfield I, Buckle AM, Savill JS, McDowall A, Haslett C, Hogg N. Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression. J Immunol 1994;153:1254-1263.
39. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995;146:3-15.
40. Uson J, Balsa A, Pascual-Salcedo D, Cabezas JA, Gonzalez-Tarrio JM, Martin-Mola E, et al. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies. J Rheumatol 1997;24:2069-2075.
41. Carson SW, Ousmanou AD, Hoyler SL. Emerging significance of P-glycoprotein in understanding drug disposition and drug interactions in psychopharmacology. Psychopharmacol Bull 2002;36:67-81.
42. Watanabe K, Oshitani N, Kamata N, Inagawa M, Yamagami H, Higuchi K, et al. Efficacy and endoscopic prediction of cytapheresis therapy in patients with refractory and steroid-dependent ulcerative colitis. Aliment Pharmacol Ther 2006;24(suppl 4):147-152.
43. Miki C, Okita Y, Yoshiyama S, Araki T, Uchida K, Kusunoki M. Early postoperative application of extracorporeal leukocyte apheresis in ulcerative colitis patients: Results of a pilot trial to prevent postoperative septic complications. J Gastroenterol 2007;42:508-509.